Furthermore, numerous studies have shown neuroprotective and neuroregenerative effects of bio-identical testosterone in addition to accelerated healing from musculoskeletal injuries (75) (76) (77) (78) (79) (80) (81) (82) (83)
The counterintuitive implication: the person who makes their training environment maximally stimulating every session will burn out faster than the person who deliberately introduces variability
It selectively decreases visceral fat and may improve cholesterol levels and insulin sensitivity in overweight females

Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
